AbbVie Advances with Cancer Candidate – Analyst BlogNASDAQAbbVie has several pipeline-related events lined up this year including data on multiple sclerosis candidate, daclizumab from the DECIDE study in mid-14 and data on Elagolix from one of the two …
Looking inside India's diplomacy debacle – gulfnews.com
Financial Express |
Looking inside India’s diplomacy debacle
gulfnews.com At the heart of the matter was America’s argument that the prosecution of Khobragade was a straightforward matter of applying the rule of law to all those residing in its territory. In India, the perception of both state and society that the arrest … US, India meet to repair tiesBayoubuzz |
Hospitals should help transplant of organs: AIIMS Director – Business Standard
|
Hospitals should help transplant of organs: AIIMS Director
Business Standard It should be made mandatory for hospitals to notify the cases of brain dead patients at the earliest as it could help increase cadaver organ donation, said Director of AIIMS M C Mishra today. “Experts should be given the responsibility to intimate … |
Texas high school football coach undergoing transplant surgery to save wife's life – Yahoo Sports (blog)
Yahoo Sports (blog) |
Texas high school football coach undergoing transplant surgery to save wife’s life
Yahoo Sports (blog) Humble (Texas) High head football coach Charles West calls his wife “my better half,” and as soon as doctors give the high school sweethearts the go-ahead on a potentially life-saving transplant surgery, there will be even more meaning behind that … |
Microparticles may reduce heart attack damage – Times of India
Times of India |
Microparticles may reduce heart attack damage
Times of India When biodegradable microparticles were injected after a heart attack, the size of the heart lesion was reduced by 50 per cent and the heart could pump significantly more blood, said a path-breaking research. “The inflammatory damage is reduced to a … |
FDA to Evaluate Idelalisib for Indolent Non-Hodgkin's Lymphoma – Monthly Prescribing Reference
|
FDA to Evaluate Idelalisib for Indolent Non-Hodgkin’s Lymphoma
Monthly Prescribing Reference The NDA submission was supported by a single arm Phase 2 study (Study 101-09) evaluating idelalisib in patients with iNHL that is refractory (non-responsive) to rituximab and to alkylating-agent-containing chemotherapy. Idelalisib is an investigational … FDA Approves Application Review For Refractory Indolent Non-Hodgkin’s …BioResearch Online (press release) |
FDA acetaminophen warning: Reports of liver failure prompts acetaminophen alert – Examiner.com
Examiner.comFDA acetaminophen warning: Reports of liver failure prompts acetaminophen alertExaminer.comAn FDA acetaminophen warning has been issued following reports of liver failure due to taking acetaminophen. In its acetaminophen alert, the FDA has …
AbbVie Advances with Cancer Candidate – Zacks.com
AbbVie Advances with Cancer CandidateZacks.comAbbVie has several pipeline-related events lined up this year including data on multiple sclerosis candidate, daclizumab from the DECIDE study in mid-14 and data on Elagolix from one of the two pivotal stud…
'Brain dead' cases should be notifiable: AIIMS director – Newstrack India
|
‘Brain dead’ cases should be notifiable: AIIMS director
Newstrack India New Delhi, Jan 16 (IANS) It should be made mandatory for every hospital to notify ‘brain dead’ cases without delay, so that donation of organs is more efficient, M.C. Mishra, director of the All India Institute of Medical Sciences, said Thursday … |
Nomura Reiterates Bullish View on Biogen (BIIB) on Tecfidera Sales – StreetInsider.com (subscription)
|
Nomura Reiterates Bullish View on Biogen (BIIB) on Tecfidera Sales
StreetInsider.com (subscription) “We remain focused on daclizumab Phase III MS data in mid-2014 given its $2bn revenue opportunity and anti-LINGO Phase II optic neuritis data in 4Q14, given its read through to the MS trial (2015E). In a year of regulatory and commercial execution, we … |